Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-01-23 Hull Hans Chief Business Officer Grant or award +40,150 251,708
2025-01-23 Hull Hans Chief Business Officer Grant or award · Stock Option (Right to Buy) +80,300 80,300
2025-01-17 Hull Hans Chief Business Officer Sale 10b5-1 −15,936 $11.20 $179K 211,558
2024-07-10 Hull Hans Chief Business Officer Sale 10b5-1 −9,900 $11.56 $114K 227,494
2024-07-09 Hull Hans Chief Business Officer Grant or award +19,337 237,394
2024-01-23 Hull Hans Chief Business Officer Grant or award +31,500 216,569
2024-01-23 Hull Hans Chief Business Officer Grant or award · Stock Option (Right to Buy) +63,000 63,000
2024-01-17 Hull Hans Chief Business Officer Sale 10b5-1 −9,786 $17.23 $169K 185,069
2023-08-04 Hull Hans Chief Business Officer Option exercise 10b5-1 +8,791 $2.08 $18K 214,905
2023-08-04 Hull Hans Chief Business Officer Sale 10b5-1 −20,050 $20.01 $401K 194,855
2023-08-04 Hull Hans Chief Business Officer Option exercise · Common Stock (Right to Buy) 10b5-1 −8,791 31,367
2023-08-03 Hull Hans Chief Business Officer Sale 10b5-1 −13,069 $20.00 $261K 206,114
2023-08-03 Hull Hans Chief Business Officer Option exercise 10b5-1 +1,800 $2.08 $4K 207,914
2023-08-03 Hull Hans Chief Business Officer Sale 10b5-1 +1,800 $20.00 $36K 206,114
2023-08-03 Hull Hans Chief Business Officer Option exercise · Common Stock (Right to Buy) 10b5-1 −1,800 40,158
2023-07-17 Hull Hans Chief Business Officer Sale 10b5-1 −17,937 $18.01 $323K 219,183
2023-07-14 Hull Hans Chief Business Officer Grant or award +35,156 237,120
2023-03-30 Hull Hans Chief Business Officer Sale 10b5-1 −9,036 $26.52 $240K 201,964
2023-03-29 Hull Hans Chief Business Officer Grant or award +17,578 211,000
2023-01-25 Hull Hans Chief Business Officer Grant or award +54,000 192,191

Page 1 of 2 · 35 trades